We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > ATAI

News List

DemeRx Receives MHRA Approval for DMX-1002 Study for Opioid Use Disorder americanpharmaceuticalreview
March 17, 2021
DemeRx IB, an atai Life Sciences (atai) platform company focused on developing ibogaine for the treatment of opioid use disorder (OUD), announced the company has approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA) to ...
ATAI Announces Neuronasal Completes Pilot Study americanpharmaceuticalreview
November 05, 2020
ATAI Life Sciences announced Neuronasal has completed its pilot study intended to show nose to brain delivery of N-acetylcysteine (NAC) in healthy volunteers.
ATAI Launches Viridia Life Sciences to Develop Novel Formulations for Mental Health Conditions americanpharmaceuticalreview
July 29, 2020
ATAI Life Sciences announced the launch of Viridia Life Sciences, a wholly-owned subsidiary developing novel formulations of N,N-Dimethyltryptamine (DMT) to treat a variety of mental health disorders.